Tower Research Capital (TRC)’s Change Healthcare Inc. Common Stock CHNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-45,625
Closed -$1.25M 6933
2022
Q3
$1.25M Buy
45,625
+44,866
+5,911% +$1.11M 0.02% 604
2022
Q2
$17K Sell
759
-804
-51% -$18.8K ﹤0.01% 3991
2022
Q1
$34K Sell
1,563
-7,184
-82% -$149K ﹤0.01% 3050
2021
Q4
$187K Sell
8,747
-2,026
-19% -$42.5K ﹤0.01% 1825
2021
Q3
$225K Buy
10,773
+10,278
+2,076% +$224K 0.01% 1708
2021
Q2
$11K Sell
495
-11,444
-96% -$263K ﹤0.01% 4357
2021
Q1
$264K Buy
11,939
+8,687
+267% +$201K ﹤0.01% 1773
2020
Q4
$60K Sell
3,252
-7,286
-69% -$120K ﹤0.01% 2924
2020
Q3
$153K Sell
10,538
-2,656
-20% -$33.8K ﹤0.01% 2809
2020
Q2
$148K Sell
13,194
-2,688
-17% -$30.2K 0.01% 2092
2020
Q1
$159K Buy
15,882
+13,953
+723% +$195K 0.01% 839
2019
Q4
$32K Sell
1,929
-14,686
-88% -$197K ﹤0.01% 1636
2019
Q3
$200K Buy
+16,615
New +$228K 0.01% 1005

Other funds holding CHNG

Tower Research Capital (TRC)'s CHNG Position: Q4 2022 in Review

Tower Research Capital (TRC) sold out of Change Healthcare Inc. Common Stock (CHNG) in Q4 2022, closing a stake of 45,625 shares — an estimated $1.25M sold.

Tower Research Capital (TRC) first reported a position in CHNG in Q3 2019 and held it in 13 quarters. The position peaked at $1.25M in Q3 2022. 1 fund tracked by Wall St. Rank holds CHNG as of Q4 2022.

  • Tower Research Capital (TRC) reported no remaining Change Healthcare Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 45,625 Change Healthcare Inc. Common Stock shares in Q4 2022, an estimated $1.25M.
  • Tower Research Capital (TRC) first reported a position in Change Healthcare Inc. Common Stock in Q3 2019 and held it in 13 quarters.
  • Tower Research Capital (TRC)'s Change Healthcare Inc. Common Stock position peaked at $1.25M in Q3 2022.
  • 1 fund tracked by Wall St. Rank held Change Healthcare Inc. Common Stock as of Q4 2022.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.